Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis

Inna L. Botchkina, Rebecca A. Rowehl, David E. Rivadeneira, Martin S. Karpeh, Howard Crawford, Antoine Dufour, Jinfang Ju, Yuan Wang, Yan Leyfman, Galina I. Botchkina

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Background: Human cancer is characterized by high heterogeneity in gene expression, varieties of differentiation phenotypes and tumor-host interrelations. Growing evidence suggests that tumor-initiating, or cancer stem cells (CSCs), may also represent a heterogeneous population. The present study was undertaken to isolate and characterize the different phenotypic subpopulations of metastatic colon cancer and to develop a working colon CSC model for obtaining highly tumorigenic and clonogenic cells in sufficient numbers. Materials and Methods: Different phenotypic cell subpopulations were isolated based on differential levels and patterns of expression of several stemness markers, including CD133, CD44, CD166 and CD49b. Stemness properties of isolated cells were tested by analysis of their ability to form floating colonospheres in vitro, to induce tumors in NOD/ SCID mice after transplantation at relatively low cell numbers, and to produce progenitors of different phenotypes. Results: The metastatic colon cancer HCT116 cell line, which expressed a majority of known CSC markers, closely resembling the patterns of expression in exfoliated peritoneal cells from several metastatic colon cancer patients, was selected as a reference material. Genome-wide microarray analysis (Affymetrix; DAVID) of CD133high CSC-enriched versus CSC-depleted cell populations revealed 4,351 differentially expressed genes with an overrepresentation of those responsible for apoptosis resistance, regulation of cell cycle, proliferation, stemness and developmental pathways. Simultaneous analysis of 84 stem cell- and metastasis-related genes with corresponding PCR arrays identified genes differentially expressed in several colon CSC phenotypic populations versus bulk tumor cells, and in relation to each other. It was found that colonospheres induced by tumorigenic cells with the highest expression of CD133 and those which were induced by CD133/CD44-negative cells possessed profoundly different stem cell-related gene expression profiles. Conclusion: The proposed approaches allow for reliable isolation and propagation of highly tumorigenic and clonogenic cells of different phenotypes. Genomic analysis of several candidate CSC phenotypic populations may contribute to the identification of novel targets for colon cancer stem cell-targeted drug development and treatment.

Original languageEnglish (US)
Pages (from-to)19-30
Number of pages12
JournalCancer Genomics and Proteomics
Volume6
Issue number1
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Stem cells
Colonic Neoplasms
Tumors
Genes
Cells
Phenotype
Population
Gene expression
Neoplasms
Stem Cells
HCT116 Cells
Inbred NOD Mouse
SCID Mice
Microarray Analysis
Transcriptome
Microarrays
Cell Cycle
Cell Count
Transplantation

Keywords

  • Cancer stem cells
  • David
  • HCT116
  • Metastatic colon cancer
  • Microarray
  • Phenotypes

ASJC Scopus subject areas

  • Biochemistry
  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Botchkina, I. L., Rowehl, R. A., Rivadeneira, D. E., Karpeh, M. S., Crawford, H., Dufour, A., ... Botchkina, G. I. (2009). Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis. Cancer Genomics and Proteomics, 6(1), 19-30.

Phenotypic subpopulations of metastatic colon cancer stem cells : Genomic analysis. / Botchkina, Inna L.; Rowehl, Rebecca A.; Rivadeneira, David E.; Karpeh, Martin S.; Crawford, Howard; Dufour, Antoine; Ju, Jinfang; Wang, Yuan; Leyfman, Yan; Botchkina, Galina I.

In: Cancer Genomics and Proteomics, Vol. 6, No. 1, 01.2009, p. 19-30.

Research output: Contribution to journalArticle

Botchkina, IL, Rowehl, RA, Rivadeneira, DE, Karpeh, MS, Crawford, H, Dufour, A, Ju, J, Wang, Y, Leyfman, Y & Botchkina, GI 2009, 'Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis', Cancer Genomics and Proteomics, vol. 6, no. 1, pp. 19-30.
Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A et al. Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis. Cancer Genomics and Proteomics. 2009 Jan;6(1):19-30.
Botchkina, Inna L. ; Rowehl, Rebecca A. ; Rivadeneira, David E. ; Karpeh, Martin S. ; Crawford, Howard ; Dufour, Antoine ; Ju, Jinfang ; Wang, Yuan ; Leyfman, Yan ; Botchkina, Galina I. / Phenotypic subpopulations of metastatic colon cancer stem cells : Genomic analysis. In: Cancer Genomics and Proteomics. 2009 ; Vol. 6, No. 1. pp. 19-30.
@article{afdba0764b254beab2ae7dbd512a42cf,
title = "Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis",
abstract = "Background: Human cancer is characterized by high heterogeneity in gene expression, varieties of differentiation phenotypes and tumor-host interrelations. Growing evidence suggests that tumor-initiating, or cancer stem cells (CSCs), may also represent a heterogeneous population. The present study was undertaken to isolate and characterize the different phenotypic subpopulations of metastatic colon cancer and to develop a working colon CSC model for obtaining highly tumorigenic and clonogenic cells in sufficient numbers. Materials and Methods: Different phenotypic cell subpopulations were isolated based on differential levels and patterns of expression of several stemness markers, including CD133, CD44, CD166 and CD49b. Stemness properties of isolated cells were tested by analysis of their ability to form floating colonospheres in vitro, to induce tumors in NOD/ SCID mice after transplantation at relatively low cell numbers, and to produce progenitors of different phenotypes. Results: The metastatic colon cancer HCT116 cell line, which expressed a majority of known CSC markers, closely resembling the patterns of expression in exfoliated peritoneal cells from several metastatic colon cancer patients, was selected as a reference material. Genome-wide microarray analysis (Affymetrix; DAVID) of CD133high CSC-enriched versus CSC-depleted cell populations revealed 4,351 differentially expressed genes with an overrepresentation of those responsible for apoptosis resistance, regulation of cell cycle, proliferation, stemness and developmental pathways. Simultaneous analysis of 84 stem cell- and metastasis-related genes with corresponding PCR arrays identified genes differentially expressed in several colon CSC phenotypic populations versus bulk tumor cells, and in relation to each other. It was found that colonospheres induced by tumorigenic cells with the highest expression of CD133 and those which were induced by CD133/CD44-negative cells possessed profoundly different stem cell-related gene expression profiles. Conclusion: The proposed approaches allow for reliable isolation and propagation of highly tumorigenic and clonogenic cells of different phenotypes. Genomic analysis of several candidate CSC phenotypic populations may contribute to the identification of novel targets for colon cancer stem cell-targeted drug development and treatment.",
keywords = "Cancer stem cells, David, HCT116, Metastatic colon cancer, Microarray, Phenotypes",
author = "Botchkina, {Inna L.} and Rowehl, {Rebecca A.} and Rivadeneira, {David E.} and Karpeh, {Martin S.} and Howard Crawford and Antoine Dufour and Jinfang Ju and Yuan Wang and Yan Leyfman and Botchkina, {Galina I.}",
year = "2009",
month = "1",
language = "English (US)",
volume = "6",
pages = "19--30",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Phenotypic subpopulations of metastatic colon cancer stem cells

T2 - Genomic analysis

AU - Botchkina, Inna L.

AU - Rowehl, Rebecca A.

AU - Rivadeneira, David E.

AU - Karpeh, Martin S.

AU - Crawford, Howard

AU - Dufour, Antoine

AU - Ju, Jinfang

AU - Wang, Yuan

AU - Leyfman, Yan

AU - Botchkina, Galina I.

PY - 2009/1

Y1 - 2009/1

N2 - Background: Human cancer is characterized by high heterogeneity in gene expression, varieties of differentiation phenotypes and tumor-host interrelations. Growing evidence suggests that tumor-initiating, or cancer stem cells (CSCs), may also represent a heterogeneous population. The present study was undertaken to isolate and characterize the different phenotypic subpopulations of metastatic colon cancer and to develop a working colon CSC model for obtaining highly tumorigenic and clonogenic cells in sufficient numbers. Materials and Methods: Different phenotypic cell subpopulations were isolated based on differential levels and patterns of expression of several stemness markers, including CD133, CD44, CD166 and CD49b. Stemness properties of isolated cells were tested by analysis of their ability to form floating colonospheres in vitro, to induce tumors in NOD/ SCID mice after transplantation at relatively low cell numbers, and to produce progenitors of different phenotypes. Results: The metastatic colon cancer HCT116 cell line, which expressed a majority of known CSC markers, closely resembling the patterns of expression in exfoliated peritoneal cells from several metastatic colon cancer patients, was selected as a reference material. Genome-wide microarray analysis (Affymetrix; DAVID) of CD133high CSC-enriched versus CSC-depleted cell populations revealed 4,351 differentially expressed genes with an overrepresentation of those responsible for apoptosis resistance, regulation of cell cycle, proliferation, stemness and developmental pathways. Simultaneous analysis of 84 stem cell- and metastasis-related genes with corresponding PCR arrays identified genes differentially expressed in several colon CSC phenotypic populations versus bulk tumor cells, and in relation to each other. It was found that colonospheres induced by tumorigenic cells with the highest expression of CD133 and those which were induced by CD133/CD44-negative cells possessed profoundly different stem cell-related gene expression profiles. Conclusion: The proposed approaches allow for reliable isolation and propagation of highly tumorigenic and clonogenic cells of different phenotypes. Genomic analysis of several candidate CSC phenotypic populations may contribute to the identification of novel targets for colon cancer stem cell-targeted drug development and treatment.

AB - Background: Human cancer is characterized by high heterogeneity in gene expression, varieties of differentiation phenotypes and tumor-host interrelations. Growing evidence suggests that tumor-initiating, or cancer stem cells (CSCs), may also represent a heterogeneous population. The present study was undertaken to isolate and characterize the different phenotypic subpopulations of metastatic colon cancer and to develop a working colon CSC model for obtaining highly tumorigenic and clonogenic cells in sufficient numbers. Materials and Methods: Different phenotypic cell subpopulations were isolated based on differential levels and patterns of expression of several stemness markers, including CD133, CD44, CD166 and CD49b. Stemness properties of isolated cells were tested by analysis of their ability to form floating colonospheres in vitro, to induce tumors in NOD/ SCID mice after transplantation at relatively low cell numbers, and to produce progenitors of different phenotypes. Results: The metastatic colon cancer HCT116 cell line, which expressed a majority of known CSC markers, closely resembling the patterns of expression in exfoliated peritoneal cells from several metastatic colon cancer patients, was selected as a reference material. Genome-wide microarray analysis (Affymetrix; DAVID) of CD133high CSC-enriched versus CSC-depleted cell populations revealed 4,351 differentially expressed genes with an overrepresentation of those responsible for apoptosis resistance, regulation of cell cycle, proliferation, stemness and developmental pathways. Simultaneous analysis of 84 stem cell- and metastasis-related genes with corresponding PCR arrays identified genes differentially expressed in several colon CSC phenotypic populations versus bulk tumor cells, and in relation to each other. It was found that colonospheres induced by tumorigenic cells with the highest expression of CD133 and those which were induced by CD133/CD44-negative cells possessed profoundly different stem cell-related gene expression profiles. Conclusion: The proposed approaches allow for reliable isolation and propagation of highly tumorigenic and clonogenic cells of different phenotypes. Genomic analysis of several candidate CSC phenotypic populations may contribute to the identification of novel targets for colon cancer stem cell-targeted drug development and treatment.

KW - Cancer stem cells

KW - David

KW - HCT116

KW - Metastatic colon cancer

KW - Microarray

KW - Phenotypes

UR - http://www.scopus.com/inward/record.url?scp=63049115530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63049115530&partnerID=8YFLogxK

M3 - Article

C2 - 19451087

AN - SCOPUS:63049115530

VL - 6

SP - 19

EP - 30

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 1

ER -